Largest Biotechnology Companies by Market Cap
Largest Biotechnology companies by market cap. The Biotechnology sector has 1,295 publicly listed stocks with a combined market cap of $2.06 Trillion. Shanghai Haohai Biological Tech Co leads the sector with a market cap of $800.47 Million. This ranking covers all Biotechnology stocks globally — from large-cap industry leaders to mid-cap and small-cap companies — ranked by market capitalization and updated daily.
Total Market Cap (USD)
Companies Listed
Largest Company
Top Biotechnology Stocks by Market Capitalization (November 2026)
Top Biotechnology stocks by market capitalization as of November 2026, covering 1,295 publicly listed companies.
| Rank | Company | Market Cap (USD) | Market Cap (Local) | Country | Price | 24h Change | 7d Change | 24h Volume |
|---|---|---|---|---|---|---|---|---|
| 301 |
Shanghai Haohai Biological Tech Co
SHG:688366 |
$800.47 Million | CN¥5.47 Billion | China | CN¥28.76 | -0.83% | -1.34% | 11.90 Million |
| 302 |
PYC Therapeutics Ltd
AU:PYC |
$794.49 Million | AU$1.12 Billion | Australia | AU$1.88 | -2.84% | +3.87% | 72.86 Million |
| 303 |
PharmaResources (Shanghai) Co. Ltd. A
SHE:301230 |
$793.00 Million | CN¥5.42 Billion | China | CN¥29.95 | +0.23% | -11.94% | 566.72 Million |
| 304 |
Alto Neuroscience, Inc.
NYSE:ANRO |
$792.19 Million | $792.19 Million | USA | $22.60 | -3.71% | +1.80% | 15.23 Million |
| 305 |
Medincell SA
PA:MEDCL |
$790.73 Million | €676.36 Million | France | €26.36 | +0.38% | +0.53% | 3.53 Million |
| 306 |
R&G PharmaStudies Co. Ltd. A
SHE:301333 |
$782.68 Million | CN¥5.35 Billion | China | CN¥55.38 | +1.24% | +7.26% | 57.69 Million |
| 307 |
Ardelyx Inc
NASDAQ:ARDX |
$782.31 Million | $782.31 Million | USA | $3.03 | -2.26% | -5.31% | 105.08 Million |
| 308 |
ALPHAMAB ONCOLO.DL-000002
F:3NK |
$781.40 Million | €668.38 Million | Germany | €0.69 | -2.82% | -12.66% | 0.00 |
| 309 |
Inventiva S.A
PA:IVA |
$771.98 Million | €660.32 Million | France | €3.18 | -4.93% | +2.42% | 16.38 Million |
| 310 |
Sana Biotechnology Inc
NASDAQ:SANA |
$769.36 Million | $769.36 Million | USA | $2.57 | -5.51% | +8.44% | 76.11 Million |
| 311 |
Replimune Group Inc
NASDAQ:REPL |
$762.97 Million | $762.97 Million | USA | $17.61 | +1.27% | +46.87% | 60.92 Million |
| 312 |
PHARMING GRP SP. ADRS
F:PHG |
$762.66 Million | €652.34 Million | Germany | €13.90 | -0.71% | -4.79% | 447.00 |
| 313 |
Gubra A/S
CO:GUBRA |
$761.00 Million | Dkr4.86 Billion | Denmark | Dkr297.80 | -1.26% | +0.95% | 1.26 Million |
| 314 |
Wuhan Keqian Biology Co Ltd
SHG:688526 |
$759.85 Million | CN¥5.19 Billion | China | CN¥11.14 | -0.62% | -5.43% | 25.14 Million |
| 315 |
Annexon Inc
NASDAQ:ANNX |
$746.94 Million | $746.94 Million | USA | $4.05 | +1.00% | +6.30% | 86.66 Million |
| 316 |
Supriya Lifescience Limited
NSE:SUPRIYA |
$737.48 Million | Rs68.19 Billion | India | Rs847.30 | -2.53% | +1.32% | 4.90 Million |
| 317 |
Jiangsu Aidea Pharmaceutical Co Ltd
SHG:688488 |
$734.57 Million | CN¥5.02 Billion | China | CN¥11.93 | -1.89% | -12.92% | 184.77 Million |
| 318 |
ArriVent BioPharma, Inc. Common Stock
NASDAQ:AVBP |
$733.21 Million | $733.21 Million | USA | $14.87 | -6.77% | -22.55% | 55.76 Million |
| 319 |
Verastem Inc
NASDAQ:VSTM |
$719.07 Million | $719.07 Million | USA | $9.75 | +0.93% | -3.08% | 124.73 Million |
| 320 |
Astria Therapeutics Inc
NASDAQ:ATXS |
$718.13 Million | $718.13 Million | USA | $5873.65 | +10.87% | +47002.25% | 16.63 Million |
| 321 |
XOMA Royalty Corporation
NASDAQ:XOMA |
$710.16 Million | $710.16 Million | USA | $40.17 | +0.00% | -8.39% | 8.18 Million |
| 322 |
Shouyao Holdings (Beijing) Co. Ltd. A
SHG:688197 |
$705.10 Million | CN¥4.82 Billion | China | CN¥32.40 | -1.19% | -2.17% | 54.14 Million |
| 323 |
Youcare Pharmaceutical Group Co. Ltd. A
SHG:688658 |
$700.63 Million | CN¥4.79 Billion | China | CN¥10.64 | -6.17% | -13.50% | 322.66 Million |
| 324 |
WAVE LIFE SCIENCES LTD.
F:1U5 |
$696.18 Million | €595.48 Million | Germany | €3.10 | -2.06% | +11.33% | 25.00 |
| 325 |
Attovia Therapeutics, Inc. Common Stock
NASDAQ:ATTO |
$693.44 Million | $693.44 Million | USA | $15.19 | -0.52% | +4.76% | 10.24 Million |
| 326 |
Oneness Biotech Co Ltd
TWO:4743 |
$691.90 Million | NT$21.96 Billion | Taiwan | NT$45.80 | -2.55% | -5.37% | 31.98 Million |
| 327 |
Wave Life Sciences Ltd
NASDAQ:WVE |
$690.72 Million | $690.72 Million | USA | $3.59 | -1.10% | +7.16% | 76.90 Million |
| 328 |
Basilea Pharmaceutica AG
SW:BSLN |
$686.09 Million | CHF542.68 Million | Switzerland | CHF70.80 | -0.98% | +2.16% | 731.42K |
| 329 |
Apnimed, Inc. Common Stock
NASDAQ:APMD |
$682.62 Million | $682.62 Million | USA | $16.40 | -5.42% | -11.49% | 10.46 Million |
| 330 |
SL Science Holding Limited Ordinary Shares
NASDAQ:SLBT |
$672.91 Million | $672.91 Million | USA | $1.20 | +2.56% | -8.40% | 1.10 Million |
| 331 |
Ascletis Pharma Inc
F:2VJ |
$666.26 Million | €569.89 Million | Germany | €0.54 | -6.90% | -11.48% | 6.00K |
| 332 |
Solid Biosciences LLC
NASDAQ:SLDB |
$664.80 Million | $664.80 Million | USA | $6.20 | -2.97% | +0.16% | 32.93 Million |
| 333 |
Sunmax Biotechnology Co Ltd
TWO:4728 |
$664.05 Million | NT$21.08 Billion | Taiwan | NT$387.00 | -3.25% | -1.78% | 379.31K |
| 334 |
Guangzhou Boji Medical and Biotechnological Co Ltd
SHE:300404 |
$651.40 Million | CN¥4.45 Billion | China | CN¥11.54 | +1.23% | +2.21% | 861.98 Million |
| 335 |
ChemPartner PharmaTech Co Ltd
SHE:300149 |
$647.79 Million | CN¥4.43 Billion | China | CN¥8.89 | +11.26% | +11.96% | 581.38 Million |
| 336 |
Sinovac Biotech Ltd
NASDAQ:SVA |
$642.44 Million | $642.44 Million | USA | $6.47 | +0.00% | +0.00% | 0.00 |
| 337 |
Achieve Life Sciences Inc
NASDAQ:ACHV |
$639.57 Million | $639.57 Million | USA | $6.83 | -5.01% | +5.08% | 32.62 Million |
| 338 |
Shenzhen Weiguang Biological Products Co Ltd
SHE:002880 |
$637.21 Million | CN¥4.35 Billion | China | CN¥19.20 | -3.03% | -2.09% | 44.13 Million |
| 339 |
Genfit S.A.
PA:GNFT |
$636.05 Million | €544.04 Million | France | €10.86 | -4.74% | +22.16% | 9.25 Million |
| 340 |
Aura Biosciences Inc
NASDAQ:AURA |
$634.79 Million | $634.79 Million | USA | $6.14 | -2.46% | -4.95% | 21.37 Million |
| 341 |
EirGenix
TWO:6589 |
$632.48 Million | NT$20.08 Billion | Taiwan | NT$66.40 | +0.00% | +0.00% | 579.36K |
| 342 |
Lexicon Pharmaceuticals Inc
NASDAQ:LXRX |
$630.76 Million | $630.76 Million | USA | $1.42 | -4.05% | -4.70% | 48.95 Million |
| 343 |
Ginkgo Bioworks Holdings
NYSE:DNA |
$620.85 Million | $620.85 Million | USA | $11.21 | -12.01% | +15.45% | 84.24 Million |
| 344 |
Alpha Tau Medical Ltd
NASDAQ:DRTS |
$614.75 Million | $614.75 Million | USA | $13.06 | -1.28% | +1.24% | 11.02 Million |
| 345 |
First Tracks Biotherapeutics, Inc. Ordinary Shares When-Issued
NASDAQ:TRAXV |
$613.49 Million | $613.49 Million | USA | $17.66 | +3.55% | -3.37% | 11.17 Million |
| 346 |
Olema Pharmaceuticals Inc
NASDAQ:OLMA |
$611.43 Million | $611.43 Million | USA | $7.00 | -4.50% | -0.28% | 31.70 Million |
| 347 |
Sagimet Biosciences Inc. Series A Common Stock
NASDAQ:SGMT |
$610.98 Million | $610.98 Million | USA | $9.92 | -4.89% | -0.30% | 34.93 Million |
| 348 |
Bicara Therapeutics Inc. Common Stock
NASDAQ:BCAX |
$604.16 Million | $604.16 Million | USA | $9.13 | -6.17% | -48.15% | 40.21 Million |
| 349 |
Nuvectis Pharma Inc
NASDAQ:NVCT |
$603.26 Million | $603.26 Million | USA | $18.48 | -0.48% | -11.54% | 4.18 Million |
| 350 |
Candel Therapeutics Inc
NASDAQ:CADL |
$597.89 Million | $597.89 Million | USA | $8.33 | -3.70% | -0.60% | 23.22 Million |
| 351 |
DBV Technologies
NASDAQ:DBVT |
$596.43 Million | $596.43 Million | USA | $9.49 | -7.77% | -1.96% | 10.91 Million |
| 352 |
Climb Bio Inc
NASDAQ:CLYM |
$588.72 Million | $588.72 Million | USA | $10.25 | -0.77% | -2.75% | 28.14 Million |
| 353 |
DBV Technologies S.A.
PA:DBV |
$588.12 Million | €503.05 Million | France | €1.70 | -6.59% | -3.35% | 33.33 Million |
| 354 |
BIOCYTOGEN PHARMA. H YC1
F:I54 |
$585.67 Million | €500.96 Million | Germany | €4.66 | -2.51% | -7.72% | 4.56K |
| 355 |
Wecome Pharmaceutical Co Ltd
SHE:300878 |
$581.59 Million | CN¥3.97 Billion | China | CN¥27.45 | -1.65% | -2.76% | 40.08 Million |
| 356 |
Beijing Konruns Pharmaceutical Co Ltd
SHG:603590 |
$577.28 Million | CN¥3.95 Billion | China | CN¥24.81 | -6.52% | -8.15% | 72.16 Million |
| 357 |
Achieve Life Sciences Inc
F:SP4P |
$574.89 Million | €491.74 Million | Germany | €6.40 | +4.92% | +12.28% | 0.00 |
| 358 |
MiMedx Group Inc
NASDAQ:MDXG |
$574.64 Million | $574.64 Million | USA | $3.88 | -2.27% | -1.27% | 36.22 Million |
| 359 |
Geron Corporation
NASDAQ:GERN |
$574.63 Million | $574.63 Million | USA | $0.89 | -5.47% | -20.85% | 290.09 Million |
| 360 |
OmniAb Inc.
NASDAQ:OABI |
$574.29 Million | $574.29 Million | USA | $5.11 | -2.29% | +6.90% | 34.47 Million |
| 361 |
Prime Medicine, Inc. Common Stock
NASDAQ:PRME |
$567.71 Million | $567.71 Million | USA | $4.72 | -9.92% | +26.54% | 140.17 Million |
| 362 |
Regulus Therapeutics Inc
NASDAQ:RGLS |
$564.95 Million | $564.95 Million | USA | $8.16 | +0.00% | +0.00% | 9.34 Million |
| 363 |
Adlai Nortye Ltd. American Depositary Shares
NASDAQ:ANL |
$560.92 Million | $560.92 Million | USA | $9.55 | -7.10% | -9.74% | 7.27 Million |
| 364 |
Neurogene Inc
NASDAQ:NGNE |
$549.63 Million | $549.63 Million | USA | $27.55 | -4.41% | +13.47% | 8.04 Million |
| 365 |
Immix Biopharma Inc
NASDAQ:IMMX |
$549.42 Million | $549.42 Million | USA | $7.68 | -3.76% | -8.02% | 37.50 Million |
| 366 |
Sage Therapeutics Inc
NASDAQ:SAGE |
$544.94 Million | $544.94 Million | USA | $8.68 | +0.00% | +0.00% | 0.00 |
| 367 |
Valneva SE
PA:VLA |
$543.87 Million | €465.20 Million | France | €2.45 | -4.10% | +2.25% | 9.30 Million |
| 368 |
ABBISKO CAYMAN DL-00001
F:8ZD |
$543.05 Million | €464.50 Million | Germany | €0.70 | -3.45% | -17.65% | 0.00 |
| 369 |
Bright Minds Biosciences Inc
NASDAQ:DRUG |
$539.47 Million | $539.47 Million | USA | $54.98 | -3.02% | +4.35% | 3.34 Million |
| 370 |
Anhui Huaheng Biotechnology Co. Ltd. A
SHG:688639 |
$536.19 Million | CN¥3.66 Billion | China | CN¥14.65 | -3.81% | -14.28% | 163.99 Million |
| 371 |
Beijing Bohui Innovation Technology Co Ltd
SHE:300318 |
$531.95 Million | CN¥3.64 Billion | China | CN¥4.45 | -1.77% | -3.68% | 186.33 Million |
| 372 |
Shanghai Model Organisms Center Inc
SHG:688265 |
$527.53 Million | CN¥3.61 Billion | China | CN¥46.24 | -4.03% | -4.91% | 91.09 Million |
| 373 |
SHANGHAI JUNSHI BIO YC1
F:8SJ |
$526.46 Million | €450.31 Million | Germany | €1.73 | -3.89% | -6.49% | 0.00 |
| 374 |
Assure Tech Hangzhou Co Ltd
SHG:688075 |
$517.90 Million | CN¥3.54 Billion | China | CN¥27.85 | -3.03% | -3.06% | 14.64 Million |
| 375 |
Zevra Therapeutics Inc.
NASDAQ:ZVRA |
$516.25 Million | $516.25 Million | USA | $10.28 | -0.77% | -0.48% | 20.43 Million |
| 376 |
4D Molecular Therapeutics Inc
NASDAQ:FDMT |
$515.62 Million | $515.62 Million | USA | $11.90 | -6.89% | +0.42% | 24.75 Million |
| 377 |
OPTHEA LTD (SP.ADR/8)
F:UKJ2 |
$512.99 Million | €438.79 Million | Germany | €3.00 | +0.00% | +0.00% | 0.00 |
| 378 |
CytomX Therapeutics Inc
NASDAQ:CTMX |
$509.88 Million | $509.88 Million | USA | $2.34 | +2.18% | -4.10% | 82.40 Million |
| 379 |
Electra Therapeutics, Inc. Common stock
NASDAQ:ETRA |
$508.41 Million | $508.41 Million | USA | $8.10 | -6.25% | -12.43% | 10.56 Million |
| 380 |
Medigen Vaccine Biologics
TWO:6547 |
$505.96 Million | NT$16.06 Billion | Taiwan | NT$48.85 | -1.81% | -3.46% | 64.50 Million |
| 381 |
Egetis Therapeutics AB (publ)
ST:EGTX |
$503.36 Million | Skr4.68 Billion | Sweden | Skr10.06 | -2.71% | +8.87% | 84.16 Million |
| 382 |
Beijing Scitop Bio Tech Co Ltd
SHE:300858 |
$501.25 Million | CN¥3.43 Billion | China | CN¥13.00 | -1.52% | -5.11% | 74.89 Million |
| 383 |
Crescent Biopharma, Inc.
NASDAQ:CBIO |
$500.70 Million | $500.70 Million | USA | $13.48 | -4.19% | +2.59% | 7.72 Million |
| 384 |
Ovid Therapeutics Inc
NASDAQ:OVID |
$496.06 Million | $496.06 Million | USA | $2.54 | -0.78% | +7.17% | 43.13 Million |
| 385 |
Hefei Lifeon Pharmaceutical Co Ltd
SHE:003020 |
$494.25 Million | CN¥3.38 Billion | China | CN¥14.80 | -4.27% | -5.25% | 75.06 Million |
| 386 |
Wuhan Hvsen Biotechnology Co Ltd
SHE:300871 |
$489.56 Million | CN¥3.35 Billion | China | CN¥16.58 | -1.13% | -12.00% | 97.56 Million |
| 387 |
TaiMed Biologics
TWO:4147 |
$489.54 Million | NT$15.54 Billion | Taiwan | NT$57.40 | -4.33% | -8.16% | 18.06 Million |
| 388 |
Arvinas Inc
NASDAQ:ARVN |
$484.55 Million | $484.55 Million | USA | $7.86 | -0.51% | +1.81% | 17.57 Million |
| 389 |
Faeth Therapeutics, Inc.
NASDAQ:FTH |
$482.96 Million | $482.96 Million | USA | $18.69 | -0.32% | -7.01% | 8.79 Million |
| 390 |
Oculis Holding AG Ordinary shares
NASDAQ:OCS |
$478.95 Million | $478.95 Million | USA | $8.26 | +0.24% | +2.10% | 8.11 Million |
| 391 |
Regenxbio Inc
NASDAQ:RGNX |
$475.29 Million | $475.29 Million | USA | $7.20 | -2.83% | +0.42% | 34.08 Million |
| 392 |
VALNEVA SE SP.ADS/2
F:AYJ0 |
$474.12 Million | €405.54 Million | Germany | €4.68 | -3.70% | -4.88% | 594.00 |
| 393 |
Monopar Therapeutics Inc
NASDAQ:MNPR |
$472.00 Million | $472.00 Million | USA | $70.32 | -2.21% | -3.11% | 3.44 Million |
| 394 |
Jiangsu Sihuan Bioengineering Co Ltd
SHE:000518 |
$464.02 Million | CN¥3.17 Billion | China | CN¥3.08 | -3.45% | -13.97% | 625.88 Million |
| 395 |
Pulike Biological Engineering
SHG:603566 |
$463.86 Million | CN¥3.17 Billion | China | CN¥9.16 | -0.11% | -9.84% | 84.31 Million |
| 396 |
I-Mab
NASDAQ:IMAB |
$456.45 Million | $456.45 Million | USA | $3.96 | -1.74% | +0.25% | 11.39 Million |
| 397 |
Prothena Corporation plc
NASDAQ:PRTA |
$455.94 Million | $455.94 Million | USA | $8.47 | -4.62% | +2.67% | 13.51 Million |
| 398 |
Iteos Therapeutics Inc
NASDAQ:ITOS |
$448.68 Million | $448.68 Million | USA | $10.15 | +0.00% | +0.00% | 0.00 |
| 399 |
Phathom Pharmaceuticals Inc
NASDAQ:PHAT |
$447.80 Million | $447.80 Million | USA | $5.74 | -7.72% | -18.12% | 38.40 Million |
| 400 |
CorMedix Inc
NASDAQ:CRMD |
$446.73 Million | $446.73 Million | USA | $5.70 | -25.46% | -29.69% | 33.38 Million |
| 401 |
Gyre Therapeutics Inc.
NASDAQ:GYRE |
$441.96 Million | $441.96 Million | USA | $4.56 | -28.94% | -22.27% | 3.37 Million |
| 402 |
Hinova Pharmaceuticals Inc. A
SHG:688302 |
$441.34 Million | CN¥3.02 Billion | China | CN¥30.46 | +0.00% | +10.04% | 48.77 Million |
| 403 |
Xiangxue Pharmaceutical
SHE:300147 |
$437.38 Million | CN¥2.99 Billion | China | CN¥4.52 | -10.14% | +7.88% | 390.57 Million |
| 404 |
Zota Health Care LImited
NSE:ZOTA |
$435.89 Million | Rs40.31 Billion | India | Rs1328.80 | +0.39% | +4.38% | 1.82 Million |
| 405 |
Entera Bio Ltd
NASDAQ:ENTX |
$434.59 Million | $434.59 Million | USA | $3.20 | +2.56% | +5.96% | 14.32 Million |
| 406 |
ENTERA BIO IS-0000769
F:5DT |
$432.85 Million | €370.24 Million | Germany | €2.72 | +0.74% | +4.62% | 800.00 |
| 407 |
Design Therapeutics Inc
NASDAQ:DSGN |
$430.65 Million | $430.65 Million | USA | $10.68 | -3.44% | +1.81% | 11.79 Million |
| 408 |
Autolus Therapeutics plc
F:6A3A |
$426.31 Million | €364.64 Million | Germany | €1.37 | -4.20% | -4.20% | 500.00 |
| 409 |
DNA Link Inc
KQ:127120 |
$426.20 Million | ₩628.90 Billion | Korea | ₩18230.00 | -5.05% | +6.86% | 4.38 Million |
| 410 |
CHA Biotech Co. Ltd
KQ:085660 |
$425.28 Million | ₩627.55 Billion | Korea | ₩6750.00 | -0.15% | -8.41% | 4.60 Million |
| 411 |
Qingdao Vland Biotech Co Ltd
SHG:603739 |
$425.06 Million | CN¥2.90 Billion | China | CN¥11.48 | -2.21% | -3.69% | 182.90 Million |
| 412 |
PureTech Health PLC
NASDAQ:PRTC |
$423.06 Million | $423.06 Million | USA | $17.38 | +4.51% | +4.95% | 97.99K |
| 413 |
Hansa Biopharma AB
ST:HNSA |
$422.20 Million | Skr3.92 Billion | Sweden | Skr39.34 | +0.00% | +4.85% | 9.00 Million |
| 414 |
Benitec Biopharma Ltd ADR
NASDAQ:BNTC |
$420.65 Million | $420.65 Million | USA | $12.70 | -2.01% | -6.62% | 3.18 Million |
| 415 |
Shanghai Shen Lian Biomedical Corp
SHG:688098 |
$420.63 Million | CN¥2.87 Billion | China | CN¥7.00 | -2.23% | -5.66% | 67.12 Million |
| 416 |
Baolingbao Biology Co Ltd
SHE:002286 |
$419.24 Million | CN¥2.87 Billion | China | CN¥7.54 | -2.46% | -8.50% | 446.77 Million |
| 417 |
Qurient Co. Ltd
KQ:115180 |
$418.94 Million | ₩618.19 Billion | Korea | ₩16590.00 | -6.95% | -17.87% | 3.24 Million |
| 418 |
C4 Therapeutics Inc
NASDAQ:CCCC |
$414.59 Million | $414.59 Million | USA | $3.37 | +2.12% | +5.97% | 65.76 Million |
| 419 |
Clarity Pharmaceuticals Ltd
AU:CU6 |
$414.45 Million | AU$585.74 Million | Australia | AU$1.57 | -5.99% | -6.27% | 67.09 Million |
| 420 |
Apellis Pharmaceuticals Inc
NASDAQ:APLS |
$412.48 Million | $412.48 Million | USA | $3.22 | +3.29% | -2.22% | 1.91K |
| 421 |
Lifecome Biochemistry Co Ltd
SHE:002868 |
$410.50 Million | CN¥2.81 Billion | China | CN¥18.05 | -2.80% | -7.91% | 38.24 Million |
| 422 |
Editas Medicine Inc
NASDAQ:EDIT |
$410.06 Million | $410.06 Million | USA | $2.67 | -8.87% | +7.23% | 56.79 Million |
| 423 |
Assembly Biosciences Inc
NASDAQ:ASMB |
$409.86 Million | $409.86 Million | USA | $20.13 | -3.50% | -0.74% | 5.35 Million |
| 424 |
Autolus Therapeutics Ltd
NASDAQ:AUTL |
$404.57 Million | $404.57 Million | USA | $1.52 | -3.80% | -3.80% | 42.81 Million |
| 425 |
BlossomHill Therapeutics, Inc. Common Stock
NASDAQ:BLSM |
$399.87 Million | $399.87 Million | USA | $13.75 | -9.60% | -13.03% | 3.83 Million |
| 426 |
Guanhao Biotech Co Ltd
SHE:300238 |
$398.09 Million | CN¥2.72 Billion | China | CN¥10.26 | -1.16% | -3.12% | 102.31 Million |
| 427 |
Eupraxia Pharmaceuticals Inc. Common Stock
NASDAQ:EPRX |
$397.88 Million | $397.88 Million | USA | $6.83 | -5.79% | -10.01% | 22.55 Million |
| 428 |
Zhejiang Shouxiangu Pharm Co
SHG:603896 |
$393.95 Million | CN¥2.69 Billion | China | CN¥13.58 | -0.29% | -3.48% | 37.04 Million |
| 429 |
Y mAbs Therapeutics
NASDAQ:YMAB |
$391.22 Million | $391.22 Million | USA | $8.61 | +0.00% | +0.00% | 760.67K |
| 430 |
Beijing Kawin Technology Share-holding Co Ltd
SHG:688687 |
$388.48 Million | CN¥2.65 Billion | China | CN¥15.53 | -2.02% | -3.24% | 73.65 Million |
| 431 |
Tectonic Therapeutic, Inc.
NASDAQ:TECX |
$386.69 Million | $386.69 Million | USA | $19.78 | -3.51% | -6.21% | 5.59 Million |
| 432 |
Pharmicell
KO:005690 |
$382.24 Million | ₩564.04 Billion | Korea | ₩9400.00 | -4.08% | -7.66% | 16.17 Million |
| 433 |
Puma Biotechnology Inc
NASDAQ:PBYI |
$382.08 Million | $382.08 Million | USA | $10.44 | -0.95% | -7.28% | 8.67 Million |
| 434 |
Rezolute Inc
NASDAQ:RZLT |
$380.35 Million | $380.35 Million | USA | $3.95 | -4.13% | +2.33% | 37.92 Million |
| 435 |
ASYMCHEM LAB.(TIAN.)H YC1
F:7K90 |
$377.48 Million | €322.88 Million | Germany | €11.60 | -0.85% | -14.71% | 2.00 |
| 436 |
Vigil Neuroscience Inc
NASDAQ:VIGL |
$375.71 Million | $375.71 Million | USA | $8.05 | +0.00% | +0.00% | 0.00 |
| 437 |
Relmada Therapeutics Inc
NASDAQ:RLMD |
$375.51 Million | $375.51 Million | USA | $3.58 | +4.07% | +8.81% | 36.63 Million |
| 438 |
Nanhua Bio Medicine Co Ltd
SHE:000504 |
$375.23 Million | CN¥2.56 Billion | China | CN¥7.77 | -2.14% | -13.57% | 1.03 Billion |
| 439 |
Capricor Therapeutics Inc
NASDAQ:CAPR |
$369.48 Million | $369.48 Million | USA | $6.38 | -3.77% | +4.08% | 83.64 Million |
| 440 |
AgomAb Therapeutics NV American Depositary Shares
NASDAQ:AGMB |
$368.87 Million | $368.87 Million | USA | $7.49 | -5.79% | -19.11% | 3.57 Million |
| 441 |
Checkpoint Therapeutics Inc
NASDAQ:CKPT |
$367.72 Million | $367.72 Million | USA | $4.26 | +0.00% | +0.00% | 8.67 Million |
| 442 |
Guangdong VTR Bio-Tech Co Ltd
SHE:300381 |
$365.76 Million | CN¥2.50 Billion | China | CN¥5.09 | -1.17% | -0.97% | 188.69 Million |
| 443 |
Yantai Zhenghai Bio-Tech Co Ltd
SHE:300653 |
$364.80 Million | CN¥2.49 Billion | China | CN¥13.85 | -1.35% | -3.89% | 40.18 Million |
| 444 |
Fennec Pharmaceuticals Inc
NASDAQ:FENC |
$359.09 Million | $359.09 Million | USA | $10.24 | -6.48% | -0.78% | 3.00 Million |
| 445 |
Aclaris Therapeutics Inc
NASDAQ:ACRS |
$353.21 Million | $353.21 Million | USA | $3.97 | -0.50% | +3.66% | 93.32 Million |
| 446 |
Hyundai Bioscience Co. Ltd
KQ:048410 |
$351.19 Million | ₩518.22 Billion | Korea | ₩5370.00 | -5.29% | -12.82% | 20.87 Million |
| 447 |
Eupraxia Pharmaceuticals Inc
TO:EPRX |
$348.80 Million | CA$482.17 Million | Canada | CA$9.52 | -6.11% | -10.61% | 2.54 Million |
| 448 |
Kyverna Therapeutics, Inc. Common Stock
NASDAQ:KYTX |
$344.71 Million | $344.71 Million | USA | $5.67 | -3.08% | -1.05% | 20.33 Million |
| 449 |
DiaMedica Therapeutics Inc
NASDAQ:DMAC |
$340.54 Million | $340.54 Million | USA | $9.25 | -2.84% | +7.18% | 5.41 Million |
| 450 |
Formycon AG
XETRA:FYB |
$338.61 Million | €289.63 Million | Germany | €18.88 | -1.15% | -0.53% | 101.31K |
How Biotechnology Companies Are Ranked by Market Cap
Biotechnology companies are ranked by market cap, the latest share price multiplied by shares outstanding, with each company counted once at its primary listing.
Track real-time market capitalization of largest public companies in the Biotechnology industry. Compare marketcap, analyze stock performance, and discover leading biotechnology corporations. View all industries